The gamma ray background from large scale structure formation

Hierarchical clustering of dark matter halos is thought to describe well the large scale structure of the universe. The baryonic component of the halos is shock heated to the virial temperature while a small fraction of the energy flux through the shocks may be energized through the first order Fermi process to relativistic energy per particle. It has been proposed that the electrons accelerated in this way may upscatter the photons of the universal microwave background to gamma ray energies and indeed generate a diffuse background of gamma rays that compares well to the observations. In this paper we calculate the spectra of the particles accelerated at the merger shocks and re-evaluate the contribution of structure formation to the extragalactic diffuse gamma ray background (EDGRB), concluding that this contribution adds up to at most 10% of the observed EDGRB.Comment: 19 pages, 4 figures. A few references and some comments added. Version in press in Astropart. Phy

A class of neutral to the right priors induced by superposition of beta processes

A random distribution function on the positive real line which belongs to the class of neutral to the right priors is defined. It corresponds to the superposition of independent beta processes at the cumulative hazard level. The definition is constructive and starts with a discrete time process with random probability masses obtained from suitably defined products of independent beta random variables. The continuous time version is derived as the corresponding infinitesimal weak limit and is described in terms of completely random measures. It takes the interpretation of the survival distribution resulting from independent competing failure times. We discuss prior specification and illustrate posterior inference on a real data example.Bayesian nonparametrics; beta process; beta-Stacy process; completely random measures; neutral to the right priors; survival analysis

Influence of wall thickness and diameter on arterial shear wave elastography: a phantom and finite element study

Quantitative, non-invasive and local measurements of arterial mechanical properties could be highly beneficial for early diagnosis of cardiovascular disease and follow up of treatment. Arterial shear wave elastography (SWE) and wave velocity dispersion analysis have previously been applied to measure arterial stiffness. Arterial wall thickness (h) and inner diameter (D) vary with age and pathology and may influence the shear wave propagation. Nevertheless, the effect of arterial geometry in SWE has not yet been systematically investigated. In this study the influence of geometry on the estimated mechanical properties of plates (h = 0.5–3 mm) and hollow cylinders (h = 1, 2 and 3 mm, D = 6 mm) was assessed by experiments in phantoms and by finite element method simulations. In addition, simulations in hollow cylinders with wall thickness difficult to achieve in phantoms were performed (h = 0.5–1.3 mm, D = 5–8 mm). The phase velocity curves obtained from experiments and simulations were compared in the frequency range 200–1000 Hz and showed good agreement (R2 = 0.80 ± 0.07 for plates and R2 = 0.82 ± 0.04 for hollow cylinders). Wall thickness had a larger effect than diameter on the dispersion curves, which did not have major effects above 400 Hz. An underestimation of 0.1–0.2 mm in wall thickness introduces an error 4–9 kPa in hollow cylinders with shear modulus of 21–26 kPa. Therefore, wall thickness should correctly be measured in arterial SWE applications for accurate mechanical properties estimation

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis

Exacerbations of chronic bronchitis (AECB) are a major cause of morbidity and mortality in patients with chronic obstructive pulmonary disease (COPD), and their impact on public health is increasing. The new fluoroquinolones have an excellent spectrum providing cover for the most important respiratory pathogens, including atypical and “typical” pathogens. Not surprisingly, different guidelines have inserted these agents among the drugs of choice in the empirical therapy of AECB. The pharmacokinetic and dynamic properties of the new fluoroquinolones have a significant impact on their clinical and bacteriological efficacy. They cause a concentration-dependent killing with a sustained post-antibiotic effect. This review discusses the most recent data on the new fluoroquinolone prulifloxacin and critically analyses its activity and safety in the management of AECB